PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.\', \'European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.\', \'National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.\', \'Department of Informatics, Istituto Superiore di Sanità, Rome, Italy.\', \'DG-SISS, Ministero della Salute, Rome, Italy.\', \'Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy.\', \'Research Coordination and Support Service, Istituto Superiore di Sanità, Rome, Italy.\', \'The members have been listed at the end of this article.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2807/1560-7917.ES.2021.26.25.2100507
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 34169819
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all